We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+12.17%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$394B
AUM Growth
+$44.6B
Cap. Flow
+$6.63B
Cap. Flow %
1.68%
Top 10 Hldgs %
19.2%
Holding
3,619
New
44
Increased
2,356
Reduced
681
Closed
81

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Financials 12.41%
3 Healthcare 11.8%
4 Consumer Discretionary 10.03%
5 Industrials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JSPR icon
3451
Jasper Therapeutics
JSPR
$29.7M
$29.1K ﹤0.01%
3,690
GALT icon
3452
Galectin Therapeutics
GALT
$316M
$28.9K ﹤0.01%
17,413
PXLW icon
3453
Pixelworks
PXLW
$38.3M
$28.8K ﹤0.01%
1,830
TSHA icon
3454
Taysha Gene Therapies
TSHA
$1.92B
$28.6K ﹤0.01%
16,140
CLIR icon
3455
ClearSign Technologies
CLIR
$28.4M
$28.4K ﹤0.01%
2,556
ASXC
3456
DELISTED
Asensus Surgical, Inc.
ASXC
$28.3K ﹤0.01%
88,725
CRVS icon
3457
Corvus Pharmaceuticals
CRVS
$1.24B
$27.6K ﹤0.01%
15,668
ADVM
3458
DELISTED
Adverum Biotechnologies
ADVM
$27.4K ﹤0.01%
3,641
OSS icon
3459
One Stop Systems
OSS
$317M
$27.1K ﹤0.01%
12,911
ELDN icon
3460
Eledon Pharmaceuticals
ELDN
$289M
$27K ﹤0.01%
14,987
MNOV icon
3461
MediciNova
MNOV
$65M
$26.8K ﹤0.01%
17,843
ASMB icon
3462
Assembly Biosciences
ASMB
$540M
$26.6K ﹤0.01%
2,704
ZDGE icon
3463
Zedge
ZDGE
$38.8M
$26.6K ﹤0.01%
11,319
DYAI icon
3464
Dyadic International
DYAI
$38.3M
$26.3K ﹤0.01%
16,336
MMAT
3465
DELISTED
Meta Materials Inc. Common Stock
MMAT
$26K ﹤0.01%
3,939
ORKA
3466
Oruka Therapeutics
ORKA
$6.31B
$25.5K ﹤0.01%
1,249
XPL icon
3467
Solitario Resources
XPL
$74.8M
$25.1K ﹤0.01%
44,899
HYFM icon
3468
Hydrofarm Holdings
HYFM
$7.96M
$24.9K ﹤0.01%
2,715
IDN icon
3469
Intellicheck
IDN
$76.3M
$24.6K ﹤0.01%
12,962
CRDF icon
3470
Cardiff Oncology
CRDF
$81.7M
$24.3K ﹤0.01%
16,399
MLSS icon
3471
Milestone Scientific
MLSS
$43M
$23.7K ﹤0.01%
34,400
CLSD
3472
DELISTED
Clearside Biomedical
CLSD
$23.7K ﹤0.01%
1,348
RAVE icon
3473
RAVE Restaurant Group
RAVE
$44.1M
$22.3K ﹤0.01%
10,012
-35,000
-78% -$79.6K
CGTX icon
3474
Cognition Therapeutics
CGTX
$97M
$22.1K ﹤0.01%
11,965
REFR icon
3475
Research Frontiers
REFR
$17.2M
$22.1K ﹤0.01%
21,870

Similar funds

Charles Schwab's Q4 2023 Portfolio in Review

As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
  • Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
  • Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
  • Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
  • Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
  • Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
  • Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.

Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.